Wei, X., Lu, C., Zhang, Y., Fan, X., Xu, C., Chen, Z., . . . Zhou, Q. (2024). Redoxhigh phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma. OncoImmunology, 13(1), . https://doi.org/10.1080/2162402X.2024.2340154
Chicago-referens (17:e uppl.)Wei, Xue-Wu, et al. "Redoxhigh Phenotype Mediated by KEAP1/STK11/SMARCA4/NRF2 Mutations Diminishes Tissue-resident Memory CD8+ T Cells and Attenuates the Efficacy of Immunotherapy in Lung Adenocarcinoma." OncoImmunology 13, no. 1 (2024). https://doi.org/10.1080/2162402X.2024.2340154.
MLA-referens (9:e uppl.)Wei, Xue-Wu, et al. "Redoxhigh Phenotype Mediated by KEAP1/STK11/SMARCA4/NRF2 Mutations Diminishes Tissue-resident Memory CD8+ T Cells and Attenuates the Efficacy of Immunotherapy in Lung Adenocarcinoma." OncoImmunology, vol. 13, no. 1, 2024, https://doi.org/10.1080/2162402X.2024.2340154.
